Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Arcus Biosciences (RCUS) over the last 5 years, with Q3 2025 value amounting to 0.64%.

  • Arcus Biosciences' Return on Invested Capital fell 1300.0% to 0.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.64%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.67% for FY2024, which is 500.0% down from last year.
  • Per Arcus Biosciences' latest filing, its Return on Invested Capital stood at 0.64% for Q3 2025, which was down 1300.0% from 0.55% recorded in Q2 2025.
  • Arcus Biosciences' Return on Invested Capital's 5-year high stood at 0.1% during Q3 2022, with a 5-year trough of 0.79% in Q1 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.5% (2023), whereas its average is 0.4%.
  • Per our database at Business Quant, Arcus Biosciences' Return on Invested Capital crashed by -7100bps in 2023 and then skyrocketed by 1300bps in 2024.
  • Quarter analysis of 5 years shows Arcus Biosciences' Return on Invested Capital stood at 0.08% in 2021, then plummeted by -652bps to 0.41% in 2022, then plummeted by -70bps to 0.71% in 2023, then rose by 18bps to 0.58% in 2024, then fell by -10bps to 0.64% in 2025.
  • Its Return on Invested Capital was 0.64% in Q3 2025, compared to 0.55% in Q2 2025 and 0.79% in Q1 2025.